arrow_back Back to App

Improving Kidney Disease Care and Treatment Access

This act aims to enhance access to kidney disease screenings and education under Medicare. It modifies the dialysis payment system to foster innovation and improve care quality. Furthermore, it expands access to Medigap supplemental insurance for individuals with kidney disease and allows them to retain private insurance longer.
Key points
Expanding kidney disease screenings as part of annual Medicare wellness visits starting 2022.
Increasing access to kidney disease education by allowing more professionals and dialysis facilities to provide it.
Adjusting dialysis payment systems to support new drugs, technologies, and improve service quality.
Ensuring Medigap supplemental insurance access for individuals with kidney disease, regardless of age, from 2022.
Allowing individuals with kidney failure to retain private health insurance for an extended period, from 12 to 42 months.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_4065
Sponsor: Rep. Sewell, Terri A. [D-AL-7]
Process start date: 2021-06-22
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Chronic Kidney Disease Improvement in Research and Treatment Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_4065.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-06-22.

What are the main provisions?

Key points include:

  • Expanding kidney disease screenings as part of annual Medicare wellness visits starting 2022.
  • Increasing access to kidney disease education by allowing more professionals and dialysis facilities to provide it.
  • Adjusting dialysis payment systems to support new drugs, technologies, and improve service quality.
  • Ensuring Medigap supplemental insurance access for individuals with kidney disease, regardless of age, from 2022.
  • Allowing individuals with kidney failure to retain private health insurance for an extended period, from 12 to 42 months.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Sewell, Terri A. [D-AL-7].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health Benefits